Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1. J Am Coll Cardiol. 2017;70(20):2536–51. https://doi.org/10.1016/j.jacc.2017.09.1096 PubMed PMID: 29145954; PMCID: PMC5825187.
Article
PubMed
PubMed Central
Google Scholar
Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G, Rubino M, Veglia F, Fiorentini C, Cipolla CM. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55(3):213–20. https://doi.org/10.1016/j.jacc.2009.03.095 PubMed PMID: 20117401.
Article
CAS
PubMed
Google Scholar
Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C, Cipolla CM. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 2004;109(22):2749–54. https://doi.org/10.1161/01.CIR.0000130926.51766.CC PubMed PMID: 15148277.
Article
CAS
PubMed
Google Scholar
Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamantia G, Cinieri S, Martinelli G, Cipolla CM, Fiorentini C. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol. 2000;36(2):517–22 PubMed PMID: 10933366.
Article
CAS
Google Scholar
Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol. 2008;26(22):3777–84. https://doi.org/10.1200/JCO.2007.14.9401 PubMed PMID: 18669466; PMCID: PMC3018290.
Article
PubMed
PubMed Central
Google Scholar
Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185–229. https://doi.org/10.1124/pr.56.2.6 PubMed PMID: 15169927.
Article
CAS
PubMed
Google Scholar
Ewer M, Yeh ET. Cancer and the heart: BC Decker; 2006.
Google Scholar
Lum BL, Svec JM, Torti FM. Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicity. Drug Intell Clin Pharm. 1985;19(4):259–64 Epub 1985/04/01. PubMed PMID: 3891276.
Article
CAS
Google Scholar
Lipshultz SE, Miller TL, Lipsitz SR, Neuberg DS, Dahlberg SE, Colan SD, Silverman LB, Henkel JM, Franco VI, Cushman LL, Asselin BL, Clavell LA, Athale U, Michon B, Laverdiere C, Schorin MA, Larsen E, Usmani N, Sallan SE. Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Pediatrics. 2012;130(6):1003–11. https://doi.org/10.1542/peds.2012-0727 PubMed PMID: 23166343; PMCID: 3507254. Epub 2012/11/21.
Article
PubMed
PubMed Central
Google Scholar
Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984;226(4673):466–8 PubMed PMID: 6093249.
Article
CAS
Google Scholar
Doroshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 1983;43(2):460–72 Epub 1983/02/01. PubMed PMID: 6293697.
CAS
PubMed
Google Scholar
Hasinoff BB. Chemistry of dexrazoxane and analogues. Semin Oncol. 1998;25(4 Suppl 10):3–9 PubMed PMID: 9768817.
CAS
PubMed
Google Scholar
Swain SM. Adult multicenter trials using dexrazoxane to protect against cardiac toxicity. Semin Oncol. 1998;25(4 Suppl 10):43–7 Epub 1998/10/13. PubMed PMID: 9768823.
CAS
PubMed
Google Scholar
Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18(11):1639–42. https://doi.org/10.1038/nm.2919 PubMed PMID: 23104132.
Article
CAS
PubMed
Google Scholar
Vavrova A, Jansova H, Mackova E, Machacek M, Haskova P, Tichotova L, Sterba M, Simunek T. Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells. PLoS One. 2013;8(10):e76676. https://doi.org/10.1371/journal.pone.0076676 PubMed PMID: 24116135; PMCID: 3792022.
Article
CAS
PubMed
PubMed Central
Google Scholar
Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97(11):2869–79 Epub 2003/05/27. doi: 10.1002/cncr.11407. PubMed PMID: 12767102.
Article
CAS
Google Scholar
Asselin BL, Devidas M, Chen L, Franco VI, Pullen J, Borowitz MJ, Hutchison RE, Ravindranath Y, Armenian SH, Camitta BM, Lipshultz SE. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404. J Clin Oncol. 2016;34(8):854–62. https://doi.org/10.1200/JCO.2015.60.8851 PubMed PMID: 26700126; PMCID: PMC4872007 online at www.jco.org. Author contributions are found at the end of this article.
Article
CAS
PubMed
Google Scholar
Lipshultz SE, Scully RE, Lipsitz SR, Sallan SE, Silverman LB, Miller TL, Barry EV, Asselin BL, Athale U, Clavell LA, Larsen E, Moghrabi A, Samson Y, Michon B, Schorin MA, Cohen HJ, Neuberg DS, Orav EJ, Colan SD. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 2010;11(10):950–61. https://doi.org/10.1016/S1470-2045(10)70204-7 PubMed PMID: 20850381; PMCID: PMC3756093.
Article
CAS
PubMed
PubMed Central
Google Scholar
Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA/ACC guideline for the Management of Patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–228. https://doi.org/10.1016/j.jacc.2014.09.017 PubMed PMID: 25260718. Epub 2014/09/28.
Article
PubMed
Google Scholar
Brush JE Jr, Kaul S, Krumholz HM. Troponin testing for clinicians. J Am Coll Cardiol. 2016;68(21):2365–75. https://doi.org/10.1016/j.jacc.2016.08.066 PubMed PMID: 27884254. Epub 2016/11/26.
Article
PubMed
Google Scholar
Ky B, Putt M, Sawaya H, French B, Januzzi JL Jr, Sebag IA, Plana JC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014;63(8):809–16. https://doi.org/10.1016/j.jacc.2013.10.061 PubMed PMID: 24291281; PMCID: PMC4286181.
Article
CAS
PubMed
Google Scholar
Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107(9):1375–80. https://doi.org/10.1016/j.amjcard.2011.01.006 PubMed PMID: 21371685; PMCID: PMC3703314. Epub 2011/03/05.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kitayama H, Kondo T, Sugiyama J, Kurimoto K, Nishino Y, Kawada M, Hirayama M, Tsuji Y. High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients. Breast Cancer. 2017;24(6):774–82. https://doi.org/10.1007/s12282-017-0778-8 PubMed PMID: 28434150. Epub 2017/04/24.
Article
PubMed
Google Scholar
Roziakova L, Bojtarova E, Mistrik M, Dubrava J, Gergel J, Lenkova N, Mladosievicova B. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation. J Exp Clin Cancer Res. 2012;31:13. https://doi.org/10.1186/1756-9966-31-13 PubMed PMID: 22321767; PMCID: PMC3293081. Epub 2012/02/11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pourier MS, Kapusta L, van Gennip A, Bokkerink JP, Loonen J, Bellersen L, Mavinkurve-Groothuis AM. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines. Clin Chim Acta. 2015;441:29–32. https://doi.org/10.1016/j.cca.2014.12.011 PubMed PMID: 25512165. Epub 2014/12/17.
Article
CAS
PubMed
Google Scholar
Kang Y, Xu X, Cheng L, Li L, Sun M, Chen H, Pan C, Shu X. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy. Eur J Heart Fail. 2014;16(3):300–8. https://doi.org/10.1002/ejhf.8 PubMed PMID: 24464946. Epub 2014/01/28.
Article
CAS
PubMed
Google Scholar
Sandoval Y, Jaffe AS. Using high-sensitivity cardiac troponin T for acute cardiac care. Am J Med. 2017;130(12):1358–65 e1. https://doi.org/10.1016/j.amjmed.2017.07.033 PubMed PMID: 28843652. Epub 2017/08/28.
Article
CAS
PubMed
Google Scholar
Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K, Yu ZX, Ferrans VJ. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol. 1999;17(7):2237–43. https://doi.org/10.1200/JCO.1999.17.7.2237 PubMed PMID: 10561281. Epub 1999/11/24.
Article
CAS
PubMed
Google Scholar
Kavsak PA, Andruchow JE, McRae AD, Worster A. Profile of Roche's Elecsys troponin T gen 5 STAT blood test (a high-sensitivity cardiac troponin assay) for diagnosing myocardial infarction in the emergency department. Expert Rev Mol Diagn. 2018;18(6):481–9. https://doi.org/10.1080/14737159.2018.1476141 PubMed PMID: 29756512. Epub 2018/05/15.
Article
CAS
PubMed
Google Scholar